Drugs News and Research

RSS

Circulating endothelial cells play a fundamental role in the development of cancer in children

Endothelial progenitor cells may play a role in the start and progression of metastatic disease in children with cancer, according to study results published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

1 Sep 2009

Dr. House's prescription: More medicine is better

Kaiser Health News reports on the impact that television shows can have on the expectations of patients and, as a result, the costs of care to the health delivery system.

1 Sep 2009

GS-101 effective in inhibiting and regressing corneal neovascularisation

Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth).

1 Sep 2009

Atrial fibrillation ablation - one of the fastest growing cardiology techniques

Atrial fibrillation ablation is one of the fastest growing techniques in cardiology and due to the very high number of patients that might be candidates to this procedure, a significant number of resources will have to be devoted to it to be able to treat them in the following years.

1 Sep 2009

Reperfusion therapy proves beneficial for patients with heart attacks

The wider use of reperfusion therapy in patients with heart attack (AMI) can save millions of lives in Europe. Effective reperfusion therapy in an AMI patient can cut the individual risk of dying by half.

1 Sep 2009

Endosense raises USD 36 million in Series B financing

Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has announced that it has received USD 36 million in Series B financing. Edmond de Rothschild Investment Partners (EdRIP) led the round, with additional participation from Neomed, Gimv, VI Partners (VI), Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.

1 Sep 2009

TransPharma's Phase 2A trial of ViaDerm-hPTH(1-34) for treating severe osteoporosis is successful

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of the Phase 2A trial of ViaDerm-hPTH(1-34) which is being developed for the treatment of severe osteoporosis.

1 Sep 2009

Phase II result reveals effectiveness of GS-101 eye drops at inhibiting corneal neovascularisation

1 Sep 2009

MultiGEN Diagnostics launches new technology for clinical testing in molecular diagnostics

San Diego-based MultiGEN Diagnostics Inc. has launched a novel multi-target DNA sequencing technology (MultiGEN) for a wide range of clinical testing in molecular diagnostics.

1 Sep 2009

Traditional lipid risk factors to be strong predictors of cardiovascular events according to a study

For patients with established heart disease who were treated with a statin, 18 novel biomarkers including C-reactive protein (CRP) did not predict future cardiovascular events such as heart attack and stroke, according to results of an analysis presented today at the 2009 European Society of Cardiology Congress in Barcelona, Spain.

1 Sep 2009

Seeplex FluA ACE subtyping test enables simultaneous detection of four major influenza A subtypes

Seegene today released a new influenza A sub-type screening test, Seeplex FluA ACE Subtyping, that enables simultaneous detection of pandemic novel influenza A (H1N1), seasonal human influenza A H1, seasonal human influenza A H3 and avian influenza A H5 in a single reaction.

1 Sep 2009

Chemists design polymer-coated nanorods for drug manufacturers

Nanoparticles combining platinum and gold act as superefficient catalysts, but chemists have struggled to create them in an industrially useful form. Rice University chemists have answered the call this week with a polymer-coated version of gold-platinum nanorods, the first catalysts of their kind that can be used in the organic solvents favored by chemical and drug manufacturers.

1 Sep 2009

House bill would strengthen federal comparative effectiveness programs

The Christian Science Monitor: "Should the US government mount a comprehensive effort to evaluate the strengths and weaknesses of various treatments for health conditions? That question is at the heart of a dispute over whether some provisions in the healthcare reform bills now under consideration in Congress eventually might lead to the rationing of care. At issue is comparative effectiveness research, which tries to figure out just how well drugs, medical devices, and surgical techniques work, compared with alternatives. Both the House and current Senate versions of health legislation would expand exisitng federal efforts in this area."

1 Sep 2009

Cardiac resynchronization therapy delays the progression of heart failure

A therapy called cardiac resynchronization can significantly delay the progression of heart failure, according to a major international study published in the New England Journal of Medicine.

1 Sep 2009

Ways to save money without letting health care suffer

Recent reports show that more and more people are cutting back on their health care or medicines to save money. But cutting back to save money isn't always the best solution, especially when it comes to doctor's appointments and required medicines

1 Sep 2009

New vaccine technology may prove beneficial for treating IGF-1 responsive disorders

Braasch Biotech LLC announces its lead vaccine for Obesity, Growth Hormone Deficiencies may have beneficial use for numerous IGF-1 responsive disorders such as diabetes, heart disease and Rett Syndrome based on initial preclinical testing in a mouse model.

1 Sep 2009

New technique developed for the treatment of cancer

A new paradigm in the way we look at cancer with important implications on how we treat it is about to be published in the British Journal of Cancer by Portuguese, Belgian and American researchers.

1 Sep 2009

Natural food compounds may play a vital role in cancer treatment

Research in the Linus Pauling Institute at Oregon State University suggests that some natural food compounds, which previously have been studied for their ability to prevent cancer, may be able to play a more significant role in treating it - working side-by-side with the conventional drugs that are now used in chemotherapy.

1 Sep 2009

Drug stores consider how reform efforts may affect drug stores

If reform passes, CVS expects profits to remain steady while benefit managers worry about other drug stores' plans to go around them and negotiate directly on price.

1 Sep 2009

Study reveals that low carbohydrate diet delayed the need for antihyperglycemic drug therapy in type 2 diabetic patients

A study published in Annals of Internal Medicine found that compared with a low-fat diet, a low-carbohydrate Mediterranean-style diet led to more favorable changes in glycemic control and coronary risk factors and delayed the need for antihyperglycemic drug therapy for overweight patients with newly-diagnosed type 2 diabetes.

1 Sep 2009

Drugs News and Research

Circulating endothelial cells play a fundamental role in the development of cancer in children

Dr. House's prescription: More medicine is better

GS-101 effective in inhibiting and regressing corneal neovascularisation

Atrial fibrillation ablation - one of the fastest growing cardiology techniques

Reperfusion therapy proves beneficial for patients with heart attacks

Endosense raises USD 36 million in Series B financing

TransPharma's Phase 2A trial of ViaDerm-hPTH(1-34) for treating severe osteoporosis is successful

Phase II result reveals effectiveness of GS-101 eye drops at inhibiting corneal neovascularisation

MultiGEN Diagnostics launches new technology for clinical testing in molecular diagnostics

Traditional lipid risk factors to be strong predictors of cardiovascular events according to a study

Seeplex FluA ACE subtyping test enables simultaneous detection of four major influenza A subtypes

Chemists design polymer-coated nanorods for drug manufacturers

House bill would strengthen federal comparative effectiveness programs

Cardiac resynchronization therapy delays the progression of heart failure

Ways to save money without letting health care suffer

New vaccine technology may prove beneficial for treating IGF-1 responsive disorders

New technique developed for the treatment of cancer

Natural food compounds may play a vital role in cancer treatment

Drug stores consider how reform efforts may affect drug stores

Study reveals that low carbohydrate diet delayed the need for antihyperglycemic drug therapy in type 2 diabetic patients

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News